• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Down 0.03%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    3.56 Down 0.12(3.26%) May 22, 4:00PM EDT
    Add to Portfolio
    Prev Close:3.68
    Open:3.72
    Bid:3.50 x 14500
    Ask:3.80 x 3300
    1y Target Est:6.50
    Beta:2.08
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:3.50 - 3.85
    52wk Range:1.56 - 5.20
    Volume:967,636
    Avg Vol (3m):1,276,240
    Market Cap:313.79M
    P/E (ttm):N/A
    EPS (ttm):-0.99
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RIGL

    Comparison

    Symbol% ChgMkt Cap
    RIGLDown 3.26%313.79M
    AMGNDown 0.16%124.37B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):31.11
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.83
    Quarterly EPS Est (Jun-15) :-0.21
    Mean Recommendation*:2.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, engages in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune diseases, immuno-oncology related diseases, and muscle disord... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback